Home › Tricuspid Valve Insufficiency › Tennessee › Nashville
Tricuspid Valve Insufficiency clinical trials in Nashville, TN
5 studies for Tricuspid Valve Insufficiency are looking for participants at sites in and around Nashville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Recruiting
- Vanderbilt University Medical Center, Nashville
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
Recruiting
- Ascension St. Thomas, Nashville
Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Recruiting
- Vanderbilt University Medical Center, Nashville
Trisol System EFS Study
Recruiting
- Vanderbilt University Medical Center, Nashville
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Recruiting
- TriStar Centennial Medical Center, Nashville
Tricuspid Valve Insufficiency trials in other cities
- New York City, NY9 studies
- Atlanta, GA7 studies
- The Bronx, NY6 studies
- Cincinnati, OH6 studies
- Chicago, IL5 studies
- Thousand Oaks, CA4 studies
- Cleveland, OH4 studies
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
- Rochester, MN4 studies
- Seattle, WA4 studies
- Portland, OR4 studies
Other studies in Nashville
- Non-Small Cell Lung Cancer97 studies
- Breast Cancer81 studies
- Metastatic Cancer70 studies
- Colorectal Cancer69 studies
- Cancer (all types)65 studies
- Ovarian Cancer49 studies
- Prostate Cancer43 studies
- Lung Cancer40 studies
- Head and Neck Squamous Cell Carcinoma39 studies
- Pancreatic Cancer39 studies
- Endometrial Cancer38 studies
- Melanoma33 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.